The entire protocol can be delivered virtually after the initial audiogram and physical assessment.
Add a Clinically-Validated Tinnitus Treatment to Your Practice
Your patients with tinnitus need more than a referral elsewhere. Neuromonics gives your practice a complete, evidence-backed tinnitus treatment solution delivered through an app your patients use at home, monitored through your provider portal, and backed by 20 years of peer-reviewed clinical evidence. No additional equipment. No lengthy in-clinic sessions. A new revenue stream and a new reason for patients to stay loyal to your practice.
New Revenue
Tinnitus is one of the most common conditions in audiology and one of the least treated. Most practices have nothing to offer beyond masking devices or a referral to CBT. Neuromonics changes that equation completely. Your practice can designate one team member to manage Neuromonics patients remotely. They complete Neuromonics University (our online clinician certification), handle all follow-up appointments via telehealth, monitor progress through the provider dashboard, and counsel patients through the protocol. The result is a structured, evidence-backed treatment for patients who currently have nowhere to go, delivered as a new revenue stream with minimal overhead.
What This Looks Like in Practice
You provide
The initial audiometric assessment. This can be done at your clinic or by a local audiologist in the patient's area. One in-person visit.
We provide training
Neuromonics University training for your designated team member. Full certification course with clinical protocol, patient forms, and final exam. Eight modules plus certification.
You handle
All follow-up appointments via telehealth. Structured check-ins at weeks 1, 2, 8, 10, 16, and 26. The provider dashboard monitors patient progress automatically.
The result
A new revenue stream with minimal overhead. A structured treatment for patients told nothing can be done. Differentiation in a market where most providers have nothing for tinnitus.
The Economics
Neuromonics creates a recurring revenue stream with minimal clinical overhead.
5.5
Total clinician hours per patient
26
Week structured protocol
85%+
Appointments via telehealth
How Neuromonics Complements Your Hearing Aid Practice
We understand the concern. Hearing aids are a significant revenue driver for most audiology practices, and any new treatment program needs to make business sense. Here is the reality. Tinnitus and hearing loss coexist in approximately 80% of cases. Hearing aids address the hearing loss. Neuromonics addresses the tinnitus. They are complementary, not competing. Offering both means your tinnitus patients stay in your practice rather than being referred elsewhere, your hearing aid patients get a complete tinnitus solution alongside their amplification, and you generate additional revenue from tinnitus treatment without reducing hearing aid sales.
We deliver the platform. You deliver the care.
Get Certified Through Neuromonics University
Neuromonics University is our online clinician training program. Eight modules covering the clinical protocol, patient identification, assessment procedures, treatment staging, counseling techniques, and troubleshooting. The course ends with a 20-question certification exam. Once certified, your team member joins the Neuromonics provider network and has full access to the clinician dashboard, patient management tools, and ongoing clinical support. Most practices are seeing patients within 30 days of starting certification.
Clinical Evidence: 83% Efficacy Across 14 Published Trials
When a patient asks why they should trust this treatment, you need an answer backed by evidence, not just a brochure. Neuromonics has the most extensive clinical evidence base of any tinnitus treatment currently available. Fourteen peer-reviewed clinical trials, 83% average efficacy rate, defined as a 40% or greater reduction in Tinnitus Reaction Questionnaire (TRQ) score. The majority of studies were conducted by independent researchers. You can offer this to patients with confidence.
83%
Average efficacy rate across published clinical studies
14
Published peer-reviewed clinical trials
97%
Of patients would recommend Neuromonics to others
| Study | Subjects | Location | Type | Success* |
|---|---|---|---|---|
| Hollywood VA | 35 | Veterans Affairs US | Independent | 96% |
| Private Practice | 470 | Australia | Neuromonics | 92% |
| T2 – NTT vs SOC | 50 | Australia | Neuromonics | 90% |
| Tavori TRI | 25 | Australia | Independent | 90% |
| T3 – Phase 1 vs 2 | 35 | Australia | Neuromonics | 86% |
| CALM Study | 51 | United States | Independent | 81% |
| Lions Ear Institute | 29 | Australia | Independent | 75% |
| Tavora AAA | 70 | US / Australia | Independent | 75% |
| Australian Veterans | 50 | Veterans Affairs AU | Independent | 74% |
| Oregon Tinnitus | 24 | United States | Independent | 72% |
| Total / Average | 1,033 | 83% |
Resources for Your Practice
Telehealth Opportunity Guide
Register for Neuromonics University
91%
of patients achieve significant reduction in tinnitus disturbance (Davis, Paki & Hanley, Ear and Hearing 2007)
97%
would recommend Neuromonics to others
50% clinic time of TRT
with comparable success in a third of the therapy time
